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Executive Summary
There are over two million patients in the United States that have cardiovascular
implantable electronic devices (CIEDs). In 2017, the Heart Rhythm Society (HRS) provided a
consensus statement with guidelines and recommendations for device management of patients
with magnetic resonance (MR) conditional as well as MR non-conditional CIEDs (Indik et al.
2017). In January 2018, the Centers for Medicare and Medicaid Services (CMS) proposed that a
qualified physician, nurse practitioner (NP), or physician assistant (PA) with expertise in
implanted permanent pacemakers (PM), implantable cardioverter defibrillator (ICD), cardiac
resynchronization therapy pacemakers (CRT-P), or cardiac resynchronization therapy
defibrillators (CRT-D) must directly supervise patients with CIEDs during magnetic resonance
imaging (MRI).
Manuscript
A comprehensive review of literature was conducted using search terms. Search terms
utilized were magnetic resonance imaging, cardiac implantable electronic devices, MRI, MRI
safety, MRI adverse effects, CIED, CIED interference, pacemaker, and implantable cardioverter
defibrillator. The following databases were accessed to search for relevant literature: Cochrane,
CINAHL, PubMed, Evidence-Based Journals, Scopus, Medscape, Heart Rhythm Society, and
American Heart Association. The search yielded 30 articles. The final yield was 12 articles.
Articles were selected for inclusion if they addressed CIEDs, MRIs, safety, safety concerns, and
written in the English language. Articles were excluded if they were more than ten years old and
focused only on specific manufacturers.
Articles were critically appraised with the Johns Hopkins Nursing Evidence-Based
Practice Non-Research and Research Evidence Appraisal Tools (Dang & Dearholt, 2018). These
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tools provide a concise appraisal of the level and quality of the evidence. Articles initially
considered were utilized to guide the literature review and selected studies. Articles were chosen
based on the type of study as well as the number and type of CIEDs reviewed. The twelve
articles selected for inclusion were prospective, single non-randomized studies, multi-center
cohort studies, a retrospective study, prospective study, randomized control trials, a metaanalysis and systemic review, technical report, abstract, and clinical review.
Prospective, Single Non-Randomized Studies
Two of the nine studies included prospective, single non-randomized studies by Nazarian
et al. (2017) and Bailey et al. (2016). Both studies reviewed CIED interrogation results before
and after the MRI with utilization of a standardized device management protocol. Device
interrogation with lead comparison was performed at enrollment, pre- and post-MRI scan, onemonth post-MRI, and three-month post-MRI. Both studies compared the effects of thoracic and
non-thoracic MRI on CIEDs. The results of these studies were consistent with other previously
published reports that demonstrated no long-term clinically significant adverse events. Bailey et
al. (2016) had a sample size of two-hundred forty-five patients and Nazarian et al. (2017) had
one thousand five hundred nine patients. Limitations included small sample sizes and low
number of cardiac MRIs but demonstrated MRI safety of PMs and ICDs.
Prospective, Multicenter Cohort Studies
Two prospective, multicenter cohort studies analyzed CIED interrogation results before
and after the MRI with the utilization of a standardized protocol. All studies were performed in a
1.5 tesla (T) MRI scanner. The prospective, multicenter study by Jung, Sebastian, and Zvereva
(2015) identified the prospective adverse event rate and parameter changes in non-MRI CIEDs
using a device registry. Russo et al. (2017) analyzed PM and ICD data and confirmed the safety
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of non-MRI conditional CIEDs that underwent clinically indicated non-thoracic MRI at 1.5T.
Device or lead failure did not occur in both studies but was not predictive of findings with testing
at higher magnetic strength greater than 1.5T.
Retrospective and Prospective Cohort Study
The only retrospective cohort study by Dandamudi et al. (2016) reviewed the device
assessment reports in the electronic medical records of patients with CIEDs before and after the
MRI with a CIED safety protocol. When a comprehensive CIED MRI protocol is followed, the
risk of performing 1.5T MRI with the device in the isocenter including pacemaker dependent
patients is low.
One prospective cohort study by Yadava et al. (2017) reviewed 277 patients who
underwent 293 scans. The CIEDs included 170 PMs and 71 ICDs. Devices were interrogated
before and after the MRI with the use of a standardized protocol. The study demonstrated no
changes in device settings during an MRI. Long-term follow-up device assessment confirmed no
adverse effects from 1.5T MRI.
Randomized Control Trials
Two randomized control trials (RCT) analyzed CIEDs before, during, and after the MRI
with the use of an MRI scan protocol. The study by Shenthar et al. (2015), evaluated MRI safety
without positioning restrictions in patients with MR conditional PM with non-MR conditional
leads. Two hundred sixty-six patients were sampled with a two to one ratio to the MRI group or
control group. There were no related complications immediately and at one-month post-MRI.
The second RCT by Wilkoff et al. (2011) evaluated PM performance and pacing capture
threshold nine to twelve weeks prior to the MRI, during the MRI, and immediately after the
MRI. Four hundred sixty-four patients were randomized to undergo an MRI scan between nine
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to twelve weeks post-CIED implantation. Patients were monitored for arrhythmias, symptoms,
and PM system function during fourteen non-clinically indicated brain and lumbar MRI
sequences. It was found that no MRI related complications occurred during or after the MRI.
Meta-analysis and Systemic Review
One meta-analysis and systematic review performed by Shah et al. (2018) utilized a
random effects model for meta-analysis of continuous variables including device lead parameters
such as capture threshold, sensing, and impedance; high-voltage ICD lead impedance, and
battery voltage change. Safety outcomes were evaluated with descriptive analysis. Indexed
articles from PubMed were queried between the years 1990-2017. The search yielded one
thousand three hundred twenty-four records to review. Seventy studies were included for the
systematic review, and five thousand ninety-nine patients were identified. The brain or cervical
spine was imaged the most and thoracic imaging was completed in seven hundred seventy-three
patients. The meta-analysis cohort included thirty-one studies. This analysis summarized the
safety profile of five thousand nine-hundred eight MRI studies in five thousand ninety-nine
patients with non-MRI conditional CIEDs in a span of twenty-five years. There were no
reported deaths and three total lead failures. There were no relevant changes in lead, battery, or
pulse generator performance. The observed changes were small, and inter-study variance was
low. The findings suggest the need for ongoing monitoring.
Technical report/Clinical review/Abstract
The technical report by Viera, Lazoura, Nicol, Rubens, and Padley (2013) analyzed data
from a multicenter device registry. Devices were interrogated before and after an MRI with the
use of a standardized protocol. The report confirmed the need for utilization of a comprehensive
safety protocol and substantiated the development of new generation MRI conditional CIEDs.
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The only clinical review by Nordbeck, Ertl, and Ritter (2015) provided a better
understanding of the structures responsible for life-threatening complications as well as technical
advances supporting the safety of MRIs for CIEDs. Clinical trials were reviewed over the last
twenty years, including fourteen PM and thirteen ICD studies. The studies assessed the outcome
in 1.5T scanners and reported there were no adverse events.
The single abstract found in the literature review demonstrated CIED safety during an
MRI with appropriate monitoring and application of a safety protocol. It provided an overview
of available data related to CIEDs and MRIs and attempted to offer up-to-date and a clinically
useful summary for practicing cardiologists.
Conclusion
In conclusion, literature reviewed between 2011 and 2018 showed non-conditional
CIEDs undergoing 1.5T MRI were evaluated pre, intra, and post-MRIs. A CIED safety protocol
was utilized in most studies. Many of the studies reported CIED reprogramming before and after
the MRI. There were minimal to no MRI related complications or adverse effects.
Findings from all the studies support the safety of the MRI for patients with conditional
as well as non-conditional CIEDs at the magnetic strength of 1.5T and validate the 2017 HRS
consensus statement demonstrated in the evidence table (Appendix A). MRIs can be performed
with appropriate monitoring and the utilization of a safety protocol. More research is needed to
evaluate the safety of MRIs at higher magnetic strength, greater than 1.5T. Observational studies
with larger sample sizes and involvement of multi-centers should also be considered. With the
evidence supporting the safety of MRIs for all CIEDs and incorporating the recent CMS
guidelines, healthcare organizations must take the opportunity to evaluate their CIED
management capabilities to comply with current staffing recommendations.
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were performed analyzed
failure did not Data from both
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The results are
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Appraisal Tool
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EXPANDING MAGNETIC RESONANCE IMAGING MANUSCRIPT
Citation

Conceptual
Framework

Yadava, M.,
None
Nugent, M.,
Krebsbach, A.,
Minnier, J., Jessel,
P., & Henrikson,
C.A. (2017).
Magnetic
resonance imaging
in patients with
cardiac implantable
electronic devices.
Journal of
Interventional
Cardiac
Electrophysiology
,50, 95-104.

Design/Method

Prospective
Cohort Study

Sample/Setting Variable Studied Measurement
and Their
Definitions
N = 277 patients Devices were
All studies were
underwent 293
interrogated
performed in a 1.5scans. The
before and after tesla MRI scanner.
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Findings
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Worth to Practice
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implantable cardioverterdefibrillator (ICD) and a
clinical indication for an
MRI were considered.
Exclusion criteria included
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and ICDs before 2000,
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leads, and pacemaker
dependent ICD patients.
Pacemaker dependent
patients were programmed
to asynchronous pacing.
Tachycardia detection and
therapies were disabled for
ICDs. Devices were
interrogated pre and postscan and at follow up 1-6
weeks later. Defibrillation
threshold testing (DFT)
was not completed postscan. Patients were
followed to monitor device
therapies.

The devices included
170 pacemakers and 71
ICDs. Thirteen scans
were aborted due to
subjective complaints
or artifact on imaging.
Post-scan and followup interrogations
showed no changes in
device settings
requiring
reprogramming or
revision. Long-term
follow-up demonstrated
that nine ICD patients
had appropriate device
shocks and one had
four inappropriate
shocks for atrial
fibrillation.

Strengths:
Data from both
pacemakers and
ICDs.
Limitations: Followup data was not
available for some
of their patients due
to the large number
of them being
referred from
outside physicians.
It was difficult to
accurately obtain
information about
device parameters.
Device malfunction
could not be ruled
out in those
patients who were
lost to follow-up.
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Research Evidence
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device assessment
pre- and post-MRI
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Measurement

Data Analysis

Findings

Appraisal:
Worth to Practice

Devices were
interrogated before
and after imaging
with reprogramming
to asynchronous
pacing in pacemaker
dependent
patients. The clinical
interpretability of the
MRI and peak and
average specific
absorption
rates (SARs, W/kg)
achieved were
determined.

Twenty-nine patients had a
pacemakers and 29 patients
had ICDs. Ten patients were
pacemaker dependent. Fiftyone patients had non-MRI
conditional devices. There
were no significant changes in
atrial and ventricular sensing
impedance, and threshold
measurements. There were no
episodes of device mode
changes, arrhythmias,
therapies delivered, electrical
reset, or battery depletion.
One study was discontinued
because the patient
experienced chest pain (not
related to the exam).

When a comprehensive CIED MRI safety
protocol is followed,
the risk of performing
1.5T magnetic
resonance studies
with the device in the
magnet isocenter,
including pacemaker
dependent patients is
low.

Strengths:
Data from both
pacemakers and ICDs.
Utilization of thoracic
scans.
Limitations:
The study had a small
sample size in
addition to the small
number of patients
with repeat MRI
exams.The
retrospective nature
of the study did not
allow for control of all
confounding
variables, did not
allow for control of all
confounding
variables.
Critical Appraisal
Tool & Rating:
John Hopkins
Research Evidence
Appraisal Tool , III
A/B.
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and Their
Definitions
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2014.
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and device
parameter
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with non-MRIconditional cardiac
devices
(pacemakers or
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nonthoracic
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Measurement

Data from
MagnaSafe
registry.

Data Analysis

Findings

Data was extracted Development of
from 1.5T MRI
MRI conditional
scans.
devices has
improved the risk
benefit. Risks
have been low;
however, minor
risks have
significant effects.

Appraisal:
Worth to Practice
Strengths:
Data from both
pacemakers and
ICDs. Studies from
1998-2014. Data
extracted from all
studies.
Limitations:
Data from all
studies only used
1.5T magnetic field.
Should test at
higher magnetic
strength.
Critical Appraisal
Tool & Rating:
John Hopkins
Research Evidence
Appraisal Tool , III
A/B.
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MRI with the use Registry
of a standardized
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Data Analysis

Findings

Appraisal:
Worth to Practice

Risks were
identified, need for
comprehensive
safety protocol.

New generation of MRI
conditional pacemakers
developed. Higher risk
with ICD and CRT
devices.

Strengths:
Identification of
risks, need for
safety protocols.
Limitations:
Data from all
studies only used
1.5T magnetic field.
Critical Appraisal
Tool & Rating:
John Hopkins
Research
Evidence
Appraisal Tool , III
A/B.
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Data Analysis

At 9-12 weeks post
implant, the MRI
group underwent MRI
at 1.5T. Primary endpoints were MRIrelated complicationfree rate and noninferiority of the MRI
group compared to
the control group with
the regard to the
proportion of patients
with increase of <0.5V
in the right atrial and
right ventricular
pacing capture
thresholds from
immediately before
MRI to 1 month post
MRI.

Findings

Appraisal:
Worth to
Practice
No MRIStrengths:
related
RCT.
complications Limitations:
occurred in 156 Data from all
MRI scanned studies only
patients who used 1.5T
were followed magnetic field.
through 1
Critical
month post
Appraisal Tool
MRI. MRI
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scans can be John Hopkins
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Research
safely.
Evidence
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conditional
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in older devices.
Defibrillator
function was
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inappropriate
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This review
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lead failure and
clinical event rates
in non-MRI
conditional
pacemaker and ICD
undergoing MRI.
Observed changes
were small and
interstudy variance
was low suggesting
that the composite
event rates offer a
reasonable estimate
of true effect. The
observed adverse
events reinforce the
need for ongoing
monitoring and
caution.

Strengths:
Large number of
studies and significant
number of patients.
Limitations:
Previously published,
largely observational
data. Unknown number
of patients were
implanted with
Medtronic model 4076
and 5076 leads which
may have lowered the
clinical risk observed
because these leads are
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review of all possible
device, lead, and MR
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Research Evidence
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Findings
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performed at
1.5T and
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radiofrequency
power
deposition
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gradient dB/dt
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Patients were
monitored for
arrhythmias,
symptoms, and
pacemaker system
function during 14
non-clinically
indicated relevant
brain and lumbar
MRI sequences.

No MRI related
complications
occurred during
or after the MRI.

Strengths:
This trial documented
the ability of the
pacemaker to be
exposed in a
controlled fashion to
MRI in a 1.5T scanner
without adverse
impact on patient
outcomes or
pacemaker function.
Limitations:
Data only from 1.5T
magnetic field. Use of
MRI scanners on
pacemaker patients
was specifically
limited to well-defined
conditions in the trial
and safe use outside
of these conditions
was not demonstrated.
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John Hopkins
Research Evidence
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Sample/Setting

Variable Studied
and Their
Definitions
Prospective
N = 245 with
Pre-MRI, atrial and
Single, Nonstable baseline
ventricular sensing
randomized study pacing indices
and thresholds.
implanted with a Using
Biotronik Entovis investigational
pacemaker and
software.
Sertox leads.
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Appraisal:
Worth to Practice

Device interrogation
was performed at
enrollment, pre and
post MRI scan, and 1
and 3 months post
MRI.

216 patients
completed the MRI
and 1-month postMRI follow up.
Statistical analysis
was based on the
proportion of the
leads or patients
satisfying end-point
criteria. Two-sided
95% CIs for the
parameters were
given.

One adverse
event possibly
related to the
implanted
system and the
MRI procedure
occurred,
adverse device
effect-free rate
of 99.6%. The
study
demonstrated
the clinical
safety and
efficacy of the
ProMRI
pacemaker
system.

Strengths:
This study
demonstrated the
safety and function
of the ProMRI
pacemaker.
Limitations:
Sample size was
insufficient to
observe rare
adverse effects of
MRI on the patient
population. The
number of cardiac
MRI was lower than
thoracic MRI and
could
underestimate the
risk of cardiac
MRI.
Critical Appraisal
Tool & Rating:
John Hopkins
Research Evidence
Appraisal Tool , II
A.
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Design/Method

Sample/Setting Variable Studied
and Their
Definitions
Prospective,
N = 1509 who
Evaluated the
Single, Nonunderwent 2103 safety of MRI,
randomized study thoracic and non- performed with
thoracic MRIs the use of a
prespecified
safety protocol.
Lead parameters
were compared
with the use of
the Wilcoxon
signed-rank test,
with MRI
examination
as the unit of
analysis.
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Appraisal:
Worth to Practice

The pacing mode
was changed to
asynchronous
mode for pacing
dependent
patients and to
demand mode for
other patients.

In 9 MRI exams,
95% CI was
reported. The
most common
notable change
in device
parameters
immediately after
MRI was a
decrease in the P
wave amplitude,
which occurred
in 1% of the
patients. Lead
parameters were
compared with
the use of the
Wilcoxon signed
rank test with
MRI examination
as the unit of
analysis.

Lead
parameters were
compared with
the use of the
Wilcoxon
signed rank test
with MRI
examination as
the unit of
analysis.

Strengths:
This study
demonstrated the MRI
safety of pacemakers
and ICDs.
Limitations:
Data was acquired at a
single center and may
not be generalizable to
other clinical settings
and MRI facilities.
Unable to obtain longterm follow up
information from 302
patients. The study did
not perform
defibrillation testing in
patients who had an
ICD. The numbers of
each individual devices
were small. Interactions
of future systems
cannot be ruled out.
Critical Appraisal Tool
& Rating:
John Hopkins Research
Evidence Appraisal
Tool , II A.
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Abstract

Variable Studied
Measurement
and Their
Definitions
This review paper 6 studies and 4
Reviewed clinical
provides an
clinical trials were trials and
overview of the reviewed.
numerous
currently
literature to
available data
study the safety
related to CIEDs
of MRIs and
and MRI and
CIEDs.
attempts to offer
an up-to date and
clinically useful
summary for the
practicing
cardiologist. Six
studies and four
clinical trials were
reviewed.
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Data Analysis

An overview of
all available MRI
conditional
devices and their
individual
restrictions was
given.

Findings

Appraisal:
Worth to Practice

With
Strengths:
appropriate This abstract
monitoring demonstrated the
and
MRI safety of
application pacemakers and
of a safety
ICDs.
protocol, MRI Limitations:
can be safely Data was limited to
performed in the 6 studies and
patients with 4clinical trials.
CIEDs.
Studies with use of
higher magnetic
strength should have
been included.
Critical Appraisal
Tool & Rating:
John Hopkins
Research Evidence
Appraisal Tool , III
A/B.
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Design/Method

Clinical Review
and Update

Sample/Setting
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Variable Studied Measurement Data Analysis
and Their
Definitions

This clinical
Reviewed clinical 14 pacemaker
review provides a trials over the last studies and 13
better
20 years.
ICD studies.
understanding of
the mechanisms
responsible for
life-threatening
complications as
well as technical
advances
allowing an
increasing
number of
pacemakers and
ICDs to safely
undergo MRIs.

14 pacemaker
studies and 13
ICD studies
assessed the
outcome in 1.5T
MR scanners.
There were no
adverse events
reported.

Findings

Appraisal:
Worth to Practice

Appropriate
monitoring and
application
of a safety
protocol, MRIs
can be safely
performed in
patients with
CIEDs.

Strengths:
This review
demonstrated the
MRI safety of
pacemakers and
ICDs.
Limitations:
Data was limited to
14 pacemaker
studies and 13 ICD
studies. Studies
with use of higher
magnetic strength
(>1.5T) should
have been
included.
Critical Appraisal
Tool & Rating:
John Hopkins
Research
Evidence
Appraisal Tool , III
A/B.

